Covid-19 and Tobacco
Study to generate evidence to support policy and practice to address tobacco use during and beyond the Covid-19 pandemic.
Smokers at higher risk
Underlying chronic health conditions such as heart or respiratory disease, cancer and diabetes are more common in smokers. These underlying conditions put smokers at a greater risk during the COVID-19 pandemic.
Tobacco control during epidemics
There is a need to better integrate responses to infectious disease epidemics and tobacco control interventions, particularly in low and middle income countries where health service capacity is limited.
This new study, led by Professor Linda Bauld, is set to build on existing work across Africa and Asia. It will generate evidence to inform policy decisions relating to public health responses during respiratory health infectious disease epidemics, such as COVID-19, with a particular focus on tobacco control interventions.
Mental and physical health of smokers
In addition, the team will investigate the social impact of the Covid-19 pandemic and its response on the mental health, physical health and quality of life of smokers and their families in Pakistan and India.
Urgent funding for research in LMICs